1147.80 -25.10 (-2.14%)

27.90% Fall from 52W High

2.0M NSE+BSE Volume

NSE 30 May, 2025 3:45 PM (IST)

Estimates Beat
Aurobindo Pharma's Q4FY25 revenue grows 10.4% YoY, beats Forecaster estimates by 2.8% See details


Aurobindo Pharma Ltd. Earnings/Conference Calls

Aurobindo Pharma Ltd. earnings concalls and investor presentations

1243 Votes:
Buy 80.13%
Sell 13.84%
Hold 6.03%
BUY
SELL
HOLD